Altre lingue Brain+ A/S

Azioni

BRAINP

DK0061670205

Mercato chiuso - Nasdaq Copenhagen Altri mercati azionari 16:59:33 21/05/2024			Variaz. 5gg	Var. 1 gen.
0,0998 ^DKK	+3,96%		+2,67%	-48,56%

07/05	Brain+ pianifica un'emissione di diritti per 9 milioni di corone danesi per finanziare le operazioni	MT
07/05	Brain+ A/S fornisce una guida agli utili per l'anno 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Brain+ informs of progress on its UK focused proof-of-business strategy plan	16/05
Brain+ A/S convenes the Annual General Meeting	07/05
Brain+ Plans DKK9 Million Rights Issue to Help Fund Operations	07/05
Brain+ publishes its Annual Report for 2023 - A year of market access, product development and a refocused commercial strategy	07/05
Brain+ A/S Provides Earnings Guidance for the Year 2024	07/05
Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan	07/05
Brain+ updates on implementation and scaling activities for its CST-Assistant in Denmark	02/05
Brain+' CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia	30/04
Brain+ releases preliminary annual financial statements for 2023	30/04
Brain+ announces a change in its Financial Calendar for 2024	29/04
Successful educational CST course held with Malteser Germany based on the CST-Assistant	26/04
Certain Shares of Brain+ A/S are subject to a Lock-Up Agreement Ending on 22-APR-2024.	22/04
Brain+ announces registration of directed issue with the Danish Business Authority	11/04
Brain+ announces registration of series TO 3 warrant exercise with the Danish Business Authority	10/04
Brain+ announces the outcome of its series TO 3 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments	26/03
Brain+ A/S specifies how to get TO 3 warrant compensation	26/03
Brain+ A/S announces last day of trading in its warrants of series TO 3	20/03
Brain+ starts UK Pilot Project on CST-Therapist Companion in partnership with Age UK	19/03
Brain+ strategy update: Focus on the UK to reach proof-of-business and commercial scaling in 2024-2025	18/03
Brain+ announces that 77% of its warrants of series TO 3 are now covered by commitments	15/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Brain+ A/S

Azioni

BRAINP

DK0061670205

Altre lingue

Filtri